60 DEGREES PHARMACEUTICALS, INC. (SXTP) Gross margin 2022–2025
60 DEGREES PHARMACEUTICALS, INC. (SXTP) gross margin by fiscal year — reported gross profit divided by reported revenue.
22.3%FY2025 · since FY2022: -93.7% → 22.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 22.3% | -14.4 pp |
| FY2024 | 36.7% | +123.8 pp |
| FY2023 | -87.1% | +6.6 pp |
| FY2022 | -93.7% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More SXTP financial trends
SXTP RevenueSXTP Net incomeSXTP Net marginSXTP Gross profitSXTP Operating incomeSXTP Operating marginSXTP Operating cash flowSXTP Free cash flowSXTP Capital expendituresSXTP Return on equitySXTP Stock buybacksSXTP Dividends paidSXTP Total assetsSXTP Total liabilitiesSXTP Shareholders’ equitySXTP overview →